Coil Transcatheter Embolization And Occlusion Devices Market Forecasted to Reach USD $2.37 Billion by 2029 at 7.7% CAGR

 Get 20% Off Market Intelligence Reports With Code ONLINE20 — Track Global Tariffs, Economic Shifts, and Sector Transformations

 

 What Is the Expected Market Growth Rate for the Coil Transcatheter Embolization And Occlusion Devices Market?
 The coil transcatheter embolization and occlusion devices market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing demand for image-guided procedures, expanding applications in trauma care, rising investments in interventional radiology, growing use of embolization in gastrointestinal bleeding management, and increasing approvals of novel coil designs.
 
 The coil transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing prevalence of aneurysms, rising adoption of minimally invasive procedures, a growing geriatric population, increasing incidence of cancer, and rising healthcare expenditure. Major trends in the forecast period include advancements in detachable coil technology, integration of microcatheters with enhanced flexibility, technological developments in imaging guidance systems, advancements in bioactive and coated coil materials, and integration of real-time 3D imaging.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24192&type=smp
  
 What Are the Primary Growth Contributors in the Coil Transcatheter Embolization And Occlusion Devices Market?
 The increasing focus on personalized medicine is expected to propel the growth of the coil transcatheter embolization and occlusion devices market going forward. Personalized medicine is a medical approach that customizes healthcare decisions and treatments based on an individual’s genetic profile, lifestyle, and environment. The increase in personalized medicine is due to advances in genomic sequencing, which make it easier and cheaper to tailor treatments to individual genetic profiles. Coil transcatheter embolization and occlusion devices support the development of personalized medicine by enabling precise, patient-specific therapies. These devices are tailored to an individual’s vascular anatomy using advanced imaging, allowing for accurate targeting of abnormal blood vessels or tumors while minimizing harm to healthy tissue. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, approving 12 new personalized medicines accounted for about 34% of all newly approved therapies, marking a significant increase compared to previous years. Therefore, the increasing focus on personalized medicine drives the growth of the coil transcatheter embolization and occlusion devices market.
 
 How Is the Coil Transcatheter Embolization And Occlusion Devices Market Segmented?
 The coil transcatheter embolization and occlusion devicesmarket covered in this report is segmented — 
 
 1) By Product Type: Detachable Coils, Pushable Coils, Other Product Types
 2) By Procedure Type: Hemorrhage Control, Vascular Occlusion, Aneurysm Treatment, Tumor Embolization, Other Procedure Types
 3) By Material: Platinum Or Platinum Alloy, Nickel Titanium, Stainless Steel, Other Materials
 4) By End-User: Hospitals, Ambulatory Surgical Centers (Ascs), Specialty Clinics, Research And Academic Institutes
 
 Subsegments:
 1) By Detachable Coils: Electrically Detachable Coils, Mechanically Detachable Coils
 2) By Pushable Coils: Fibered Coils, Non-Fibered Coils
 3) By Other Product Types: Framing Coils, Filling Coils, Liquid Embolic Agents
 
 Which Trends Are Most Likely to Influence Coil Transcatheter Embolization And Occlusion Devices Market Growth in the Next Decade?
 Major companies operating in the coil transcatheter embolization and occlusion devices market are focusing on developing innovative products, such as advanced medical implants, to enhance precision, reduce procedure time, and support minimally invasive treatment approaches. Advanced medical implants are sophisticated, long-term medical devices surgically placed inside the body to replace, support, or enhance biological functions, often incorporating cutting-edge technologies such as sensors, electronics, or drug delivery systems. For instance, in March 2022, Artio Medical Inc., a US-based medical device company, received approval from the FDA for 510(k) clearance for its Solus Gold Embolization Device, a next-generation product designed for peripheral vascular occlusion. This device is intended to obstruct or reduce the blood flow rate in the peripheral vasculature, addressing the limitations of current occlusion devices, particularly in challenging anatomical situations.
 
 Which Companies Hold the Largest Share in the Coil Transcatheter Embolization And Occlusion Devices Market?
 Major companies operating in the coil transcatheter embolization and occlusion devices market are Johnson and Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Medical Corporation, Kaneka Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Asahi Intecc Co. Ltd., Balt Extrusion SAS, Phenox GmbH, Acandis GmbH & Co. KG, B. Braun Interventional Systems Inc., EndoShape Inc., Shape Memory Medical Inc., Artio Medical Inc., Medico’s Hirata Inc. 
 
 Get the full coil transcatheter embolization and occlusion devices market report here:
 https://www.thebusinessresearchcompany.com/report/coil-transcatheter-embolization-and-occlusion-devices-global-market-report
 
 How Are Market Trends Differentiating Across Key Regions in the Coil Transcatheter Embolization And Occlusion Devices Market?
 North America was the largest region in the coil transcatheter embolization and occlusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coil transcatheter embolization and occlusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company